Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_assertion description "[Significant genes in myeloma plasma cells from patients that were associated with early-onset bortezomib-induced peripheral neuropathy were the enzyme coding genes RHOBTB2 (upregulated by 159 times; p=4510(-5)), involved in drug-induced apoptosis, CPT1C (144 times; p=2910(-7)), involved in mitochondrial dysfunction, and SOX8 (168 times; p=42810(-13)), involved in development of peripheral nervous system.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_assertion evidence source_evidence_curated NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_assertion SIO_000772 20864405 NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_assertion wasDerivedFrom ctd_human-20130708 NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_assertion wasGeneratedBy ECO_0000218 NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP30698.RA9eLojfytUxMazlxPiRUSiWA_2VUdyYLoFQ4Phu7UIcY130_provenance.